New FP7 eHealth Project - Avert-IT

A consortium comprising six of Europe's leading hospitals, Glasgow University, Philips Medizin, and a Scottish SME - C3 Amulet Ltd. has been awarded a European Commission grant to lead a consortium researching the prediction of adverse events in the care of brain injury patients. The grant, totaling € 1.7 millions has been awarded under Framework 7, ICT-2007 5.1 Advanced ICT for Risk Assessment and Patient Safety.

Intensive Care patients can experience Adverse Events associated with sudden episodes of low blood pressure. These Adverse Events may impact all of the main organs resulting in longer lengths of stay, increased care costs and reducing quality of outcomes. Existing technologies enable to clinicians to know when these events have occurred and treat the effects.

Medical techniques for avoiding Adverse Events currently exist, but clinicians don#t have a reliable way to predict the occurrence, so there’s no opportunity for intervention.

Research indicates average lengths of stay can be reduced by up to 30%, and outcomes improved for a similar proportion of patients, if these Adverse Events can be avoided through prediction and intervention. Potential savings across the EU exceed 5 billion euros, annually.

A model for predicting Adverse Events offers potential for improving outcomes across a wide range of conditions and or illnesses.

The Objectives
The main objectives of the project are:

  • Understanding the association between multiple patient parameters and arterial hypotension (sudden drop in blood pressure)
  • Development of a software application to predict the occurrence of arterial hypotension based on recognition of the associations described above
  • Validation of the solution in clinical trials
  • Exploitation model for the commercialisation of the software in product/service sales across international markets

The Resources
The main research will focus on combining resources:

  • Historic patient care data from 22 specialist brain injury units across Europe
  • Grid technologies for secure data access across multiple specialist units and hospitals
  • Baysian Artificial Neural Network (BANN) techniques for analysing data
  • Specialists in treating TBI from 6 leading hospitals, in Sweden, Germany, Italy, Spain, Lithuania and Scotland
  • C3 Amulet's expertise in device monitoring, data analysis and reporting, and software development, distribution and support

The Outputs
C3 Amulet has exclusive access to the results of the research for commercial exploitation in products and services. Potential opportunities for that exploitation include:

  • Monitoring of Intensive Care Patient treatment
  • Clinical trials of both drugs and medical devices
  • BANN techniques for asset performance management and environmental monitoring and control

Consortium Members

  • C3 Amulet Ltd
  • Pera Innovation Ltd.
  • Uppsala Universitet
  • Universitätsklinikum Heidelberg
  • Azienda Ospedaleria San Gerardo Di Monza
  • Kauno Technologijos Universitetas
  • The University Of Glasgow
  • Greater Glasgow Health Board
  • Hospital Universitari Vall d'Hebron
  • Philips Medizin Systeme Böblingen Gmbh.

For further informaton, please visit:
http://avertit.wordpress.com

About C3 Amulet Ltd. Since 1995 C3 Amulet Ltd has led the software industry in Asset Performance Management solutions for Oil and Gas, Utilities and other asset based industries. The Avert-IT project brings together C3’s expertise in transforming device level data and the Universities expertise in patient care, enabling the drive to evidence based medicine through monitoring and analysis.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Computer Models Open Door to Far Mor…

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only...

New Biomarkers to Detect Colorectal Canc…

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer. In a...

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...

AI Model Identifies Potential Risk Genes…

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can...

AI Tool that may Assist Underserved Hosp…

As the fields of healthcare and technology increasingly evolve and intersect, researchers are collaborating on the best ways to use emerging technologies such as artificial intelligence (AI) to care for...